INTRODUCTION
Autophagy is an important catabolic process for maintaining human health, as it prevents various diseases including cancers, neurodegenerative disorders, and diabetes (Levine and Kroemer, 2008; Mizushima et al., 2008) . During autophagy, a double-membrane autophagosome engulfs cargo such as damaged organelles, cytosol, and microorganisms. The autophagosome then fuses with the lysosome, where its internal components are degraded by acid hydrolases (Levine and Klionsky, 2004) . Current understanding of autophagy has been greatly expanded by S. cerevisiae genetic screening; 35 autophagyrelated (ATG) genes have been identified, and most of them are conserved across higher eukaryotes (Inoue and Klionsky, 2010; Nazarko et al., 2011; Suzuki et al., 2010) . Interestingly, very few ATG proteins are implicated in autophagosome maturation, albeit substantial evidence suggests that this process is highly regulated (Eskelinen, 2005; Kim and Klionsky, 2000) . Recent studies in eukaryotes have implicated SNARE proteins (Abeliovich et al., 1999; Darsow et al., 1997; Ishihara et al., 2001; Moreau et al., 2011; Nair et al., 2011) , endosomal COPs (Ishihara et al., 2001; Razi et al., 2009) , the ESCRT III complex (Lee et al., 2007; Rusten et al., 2007) , the HOPS complex (Nickerson et al., 2009 ), LAMP proteins (Eskelinen et al., 2002; Tanaka et al., 2000) , small GTPase Rab proteins (Gutierrez et al., 2004; Jager et al., 2004; Kimura et al., 2007) , the class III phosphatidylinositol 3-kinase (Liang et al., 2008; Matsunaga et al., 2009; Sun et al., 2010 Sun et al., , 2011 , and chaperone HSP70 family proteins (Leu et al., 2009) as critical players in autophagosome maturation. However, the detailed molecular mechanism dictating fusion specificity between autophagosomes and lysosomes is still unknown.
Among Atg proteins, Atg5 is an essential gene for autophagy that is constantly conjugated to an ubiquitin-like protein, Atg12, through an enzymatic cascade (Mizushima et al., 1998) . The conjugated Atg12-Atg5 interacts with Atg16 and induces its oligomerization to form an $350 kd complex in yeast (Kuma et al., 2002) or an $800 kd complex in mammals (Mizushima et al., 2003) . The Atg12-Atg5-Atg16 complex localizes to nascent autophagosomes (Mizushima et al., 2001 (Mizushima et al., , 2003 and functions upstream to the LC3 lipidation and its autophagosome targeting (Fujita et al., 2008; Hanada et al., 2007) . The biological functions of Atg5 in mammalian development (Kuma et al., 2004 ) and a variety of physiological processes (Baerga et al., 2009; Cadwell et al., 2008; Hara et al., 2006; Jounai et al., 2007) have already been illustrated in mouse genetic studies.
TECPR1 is a component of the autophagy network that was identified through its interaction with Atg5 (Behrends et al., 2010) . It has also been implicated in selective autophagy against bacterial pathogens (Ogawa et al., 2011) . However, its function in canonical autophagy is not clear. We have identified TECPR1 as a binding partner of the Atg12-Atg5 conjugate in an independent study. We show that TECPR1 and Atg16 exist in two mutually exclusive complexes with the Atg12-Atg5 conjugate. TECPR1 resides on lysosomes and recruits Atg12-Atg5 to autolysosomes. Remarkably, we demonstrate that TECPR1 plays a crucial function in autophagosome maturation and promotes autophagosome-lysosome fusion by associating with both the Atg12-Atg5 conjugate and PtdIns(3)P. Through this study, we have uncovered a previously unknown critical function of the Atg12-Atg5-TECPR1 complex in autophagosome maturation and propose that the interaction between TECPR1 and Atg12-Atg5 provides fusion specificity between autophagosomes and lysosomes.
RESULTS

TECPR1 Interacts with the Atg12-Atg5 Conjugate
To dissect the regulation of Atg5 in autophagy, we performed a tandem affinity purification using tagged full-length Atg5 (ZZ-Atg5-FLAG) as the bait to purify the Atg5 complex. In the Atg5 complex, we identified free Atg5, the Atg12-Atg5 conjugate, Atg16, and TECPR1 (Tectonin b-propeller repeat-containing protein 1, or KIAA1358) ( Figure 1A , left panel). TECPR1 has recently been identified in the autophagy interaction network through its associations with Atg5, Atg12, Atg3, and several other proteins (Behrends et al., 2010) . To consolidate the Atg5-TECPR1 complex formation, we performed reciprocal affinity purification for the TECPR1 cellular complex; only the Atg12-Atg5 conjugate was present as a stoichiometric component of the TECPR1 complex ( Figure 1A, right panel) . Surprisingly, Atg16 or other potential associated proteins failed to be detected in the TECPR1 complex, suggesting either that they do not exist in this complex or that their interactions with TECPR1 are relatively weak.
The interaction of TECPR1 and Atg5 was further confirmed by coimmunoprecipiatation experiments. Full-length TECPR1 precipitated with the Atg12-Atg5 conjugate, free Atg5, and free (A) Silver staining of the tandem affinity-purified Atg5 complexes or TECPR1 complexes in HEK293T cells. Proteins noted on the gel were identified by mass spectrometry. (B) Reciprocal coimmunoprecipitation of TECPR1 and Atg12-Atg5. HEK293T cells were transfected with TECPR1-FLAG and Atg5-HA. Whole-cell lysate was immunoprecipitated with anti-FLAG or anti-HA agarose and analyzed by western blotting. (C) Domain structure of TECPR1. TECPR1 contains a pleckstrin homology (PH, aa 611-717) domain, an Atg12-Atg5-interacting region (AIR, aa 566-610), nine b-propeller repeats (TECPR, aa 209-240, 254-285, 301-332, 344-376, 729-756, 953-984, 1044 (TECPR, aa 209-240, 254-285, 301-332, 344-376, 729-756, 953-984, -1075 (TECPR, aa 209-240, 254-285, 301-332, 344-376, 729-756, 953-984, , 1087 (TECPR, aa 209-240, 254-285, 301-332, 344-376, 729-756, 953-984, -1127 , and two dysferlin domains (aa 64-170, 816-922) . (D) Amino acids 566-610 of TECPR1 are essential for Atg12-Atg5 binding. Atg5-HA was coexpressed with TECPR1-FLAG or different mutants as indicated. Whole-cell lysate was immunoprecipitated with anti-FLAG agarose, followed by immunoblotting with anti-HA antibody. (E) The AIR domain of TECPR1 is sufficient for Atg12-Atg5 binding. Whole-cell lysate was immunoprecipitated with anti-FLAG agarose. See also Figure S1 . Atg12 ( Figure 1B and see Figure S1 available online). However, Atg16 consistently failed to interact with TECPR1 ( Figure S1A ), indicating that Atg16 and TECPR1 exist in distinct complexes with Atg12-Atg5. Domain analysis indicated that TECPR1 contains a pleckstrin homology (PH) domain, nine b-propeller repeats (TECPR), and two dysferlin domains ( Figure 1C ). To investigate which region mediates the interaction between TECPR1 and Atg12-Atg5, deletion mutagenesis and coimmunoprecipitation assays were performed. Atg12-Atg5 interacts with the N terminus of TECPR1 ( Figure 1D, lanes 2 and 3) . Neither the PH domain nor the TECPR repeats are required for Atg12-Atg5 binding ( Figure 1D , lanes 4 and 5). However, a region spanning from aa 566 to aa 610 adjacent to the PH domain is necessary and sufficient to bind to Atg12-Atg5 ( Figure 1D , lane 8; and Figure 1E) . This region is therefore named as AIR (Atg12-Atg5 interacting region) ( Figure 1C ). The TECPR1 mutant with AIR deletion still binds free Atg5 but has no interaction with the Atg12-Atg5 conjugate ( Figure 1D , lane 8). In addition, an N-terminal region of TECPR1 (aa 1-208) containing one of the dysferlin domains is able to interact with free Atg5 but not with the Atg12-Atg5 conjugate ( Figure 1D , lane 9). As a control, no Atg12-Atg5 is pulled down with beads alone ( Figure 1D , lane 10). In summary, TECPR1 binds to the Atg12-Atg5 conjugate via the AIR region and interacts with free Atg5 likely through the dysferlin domain.
TECPR1 Localizes to Mature Rather Than Early Autophagic Structures
If TECPR1 and Atg16 exist in distinct Atg12-Atg5 complexes as indicated in Figure 1 and Figure S1 , we speculated that their relative localization on autophagosomes might also be different. To investigate the subcellular distribution of TECPR1, we coexpressed Atg5-HA, Atg16-Myc, and TECPR1-FLAG in different combinations in U 2 OS cells. As expected, Atg16 colocalized with Atg5 in cellular puncta ( Figure 2A , upper panel; Figure 2B ). Remarkably, TECPR1 also significantly colocalized with Atg5 in cellular puncta ( Figure 2A , middle panel; Figure 2B ). However, there was a limited overlap between TECPR1 and Atg16 (Figure 2A , lower panel; Figure 2B ). To visualize the spatial relationship among Atg5, Atg16, and TECPR1, we coexpressed mCherry-Atg5, EGFP-Atg16, and TECPR1-FLAG in U 2 OS cells to examine their subcellular distributions. In cells expressing Atg16, Atg5, and TECPR1, the Atg5 signal overlapped with either Atg16 or TECPR1 ( Figure S2A ).
To exclude the possibility that the appearance of TECPR1 puncta is due to overexpression artifacts, we detected its subcellular localization at physiological levels. Since current commercially available or homemade TECPR1 antibodies are not suitable for immunostaining, we established a U 2 OS cell line that stably expresses TECPR1-FLAG in a doxycycline-inducible manner. In this cell line, the expression of TECPR1-FLAG is tightly controlled by doxycycline supplementation. By using an extremely low concentration of doxycycline (2 ng/ml), TECPR1-FLAG was expressed at a level comparable to the endogenous TECPR1 level as detected by an anti-TECPR1 antibody (Figure 2C, lane 4) . Under this condition, TECPR1 was consistently stained as cytosolic puncta ( Figure 2D ). After inducing autophagy by treating cells with the mTOR inhibitor rapamycin, the amount of TECPR1 cellular puncta increased, and more than 50% of them colocalized with endogenous LC3 ( Figure 2D and Figure S2B ). Significant overlap between TECPR1 and LC3 was also observed when cells were treated with chloroquine (CQ) ( Figure 2D and Figure S2B ). CQ is a lysosomotropic agent that raises the pH in the lumen of lysosomes and/or autolysosomes, therefore compromising autophagic degradation and accumulating mature autophagic vacuoles (Poole and Ohkuma, 1981) . Upon CQ treatment, TECPR1 and LC3 were colocalized on the ring-like autophagic structures ( Figure 2D ). Since CQ did not promote the colocalization of TECPR1 with Atg16 ( Figure S2C ), these ring-like autophagic structures must represent mature rather than early autophagic structures, indicating that TECPR1 might reside on mature autophagic structures.
TECPR1 Localizes to Autolysosomes
Upon formation, autophagosomes fuse with lysosomes to form autolysosomes that are marked by both autophagosome and lysosome markers. Because we suspected that TECPR1 might reside on late autophagic structures, we examined the colocalization of TECPR1 with lysosome markers. TECPR1 did not colocalize with the early endosome marker EEA1 (Figure S3A ), but significantly colocalized with the lysosome marker LAMP-2 in a subset of cellular puncta ( Figure 3A ). The amount of cells exhibiting TECPR1 puncta and the ratio of TECPR1 puncta per cell significantly increased upon CQ treatment (Figures 3B and 3C) ; essentially all TECPR1 puncta overlapped with LAMP-2 ( Figures S3B and S3C ). These data consequently suggest that TECPR1 resides on lysosomes/autolysosomes.
The CQ-inducible TECPR1 lysosomal staining is not due to changes in protein levels, as TECPR1 expression was kept constant throughout treatments ( Figure S3D ). TECPR1 membrane association was also confirmed using biochemical fractionation. In U 2 OS cells inducibly expressing TECPR1, LAMP-1 cofractionated with TECPR1 in both light (P13) and heavy (P100) membrane fractions ( Figure S3E ). TECPR1 also made the Atg12-Atg5 conjugate translocate to membrane fractions but had no effect on Atg16. As controls, GAPDH and LC3-I form were only present in the cytosolic fraction (S100), and LC3-II showed up in the light membrane fraction ( Figure S3E ). Consequently, these data strongly support the notion that TECPR1 localizes to lysosome membranes.
TECPR1 puncta were significantly induced upon CQ treatment. We reasoned this inducibility was due to the accumulation of autolysosomes and tested it by imaging analysis. Colocalization between EGFP-LC3 and LAMP-2 was dramatically increased upon CQ treatment (Figures S3F and S3G) , suggesting that autolysosomes accumulate in the presence of CQ. EGFP is normally deprotonated in acidic lysosomes. However, the deprotonation and subsequent loss of EGFP fluorescence is attenuated in the CQ-induced autolysosomes as CQ raises the pH in these organelles. To confirm autolysosome accumulation in CQ-treated cells, we observed the ultrastructure of these cells using the electron microscope. Remarkably, in CQ-treated U 2 OS cells, a massive accumulation of large (diameter 1-3 mm) autophagic vacuoles was observed ( Figure 3D ). These vacuoles were surrounded by a single membrane and contained undegraded materials, closely resembling autolysosomes accumulated in Gnptab À/À (UDP-N-acetylglucosamine-lysosomal enzyme) exocrine gland cells (Boonen et al., 2011) . Hence, we conclude that CQ treatment leads to autolysosome accumulation. We further examined the distribution of EGFP-TECPR1 in CQ-treated cells by cryo-immunolabeling. In a procedure with a mild fixation condition and embedding without dehydration, we found that gold particles, representing EGFP-TECPR1, were surrounding the large autolysosomes in CQ-treated U 2 OS cells ( Figure 3E ). The pattern of these particles is similar to the LAMP-1 staining on the autolysosomes accumulated in Gnptab À/À exocrine gland cells (Boonen et al., 2011) , therefore indicating that TECPR1 locates to the autolysosome membrane.
TECPR1 Recruits Atg12-Atg5 to Autolysosomes
If TECPR1 localizes to autolysosomes, its overlap with Atg5 implies that Atg5 may also be recruited to autolysosomes. Atg5 puncta were rarely detected in unstressed U 2 OS cells ( Figure 4A and Figure S4A ). However, in CQ-treated cells, a moderate induction of Atg5 puncta was observed, and these puncta colocalized with the lysosome marker LAMP-2 ( Figure 4A and Figure S4A ). Remarkably, with TECPR1 overexpression and CQ treatment, the amount of Atg5 and TECPR1 puncta dramatically increased, and these puncta colocalized with LAMP-2 (Figure 4A and Figure S4A ). The inducibility of Atg5 autolysosomal localization is rather surprising, as it extends the classic idea that Atg5 localizes exclusively to phagophores or isolation membranes (Mizushima et al., 2001) . Given the interaction between Atg5 and TECPR1, we speculated that Atg5 autolysosomal distribution is dependent on TECPR1. To investigate the requirement of TECPR1 in Atg5 recruitment, we established an inducible U 2 OS TECPR1 knockdown cell line. The autolysosomal localization of Atg5 upon CQ treatment was completely abolished in TECPR1-depleted cells ( Figure 4B and Figure S4B ), indicating that TECPR1 mediates the autolysosomal distribution of Atg5.
TECPR1 Is Required for Autophagosome Maturation
Upon depletion of TECPR1, we observed the accumulation of both the lipid conjugated form of LC3 (LC3-II), a faithful autophagosome marker, and p62, an autophagic substrate ( Figures 5A-5C ). This suggests that without TECPR1, autophagic degradation is impaired. We also set up a TECPR1-depleted cell line in HeLa cells with TECPR1 shRNA lentiviral particles, and a similar result was obtained ( Figure S5A ). To better understand the nature of accumulated vesicles upon TECPR1 knockdown, these cells were observed using transmission electron microscopy. Remarkably, we observed the accumulation of numerous autophagic vacuoles ( Figures 5D and 5E ), further confirming that TECPR1 depletion impairs autophagic degradation.
Lastly, we utilized a GFP-mRFP-LC3 marker to analyze autophagosome maturation in TECPR1-depleted cells (Kimura et al., 2009) . Because GFP loses its fluorescence from deprotonation in acidic lysosomes, autophagosomes display both green and red fluorescence, whereas autolysosomes are only red. Hence, autophagosome maturation is indicated by a dramatic increase in the number of red-only autolysosomes Mizushima et al., 2010) . In starved U 2 OS cells, about 70% of LC3-positive autophagic vacuoles are only red, suggesting that autolysosomes constitute the majority of autophagic vacuoles upon starvation ( Figures 6A and 6B) . However, upon starvation in TECPR1-depleted cells, $90% of LC3 puncta are yellow (convergence of green and red signals). Therefore, the amount of red-only LC3-positive vacuoles representing autolysosomes is reduced to less than 10% (Figures 6A and 6B) . We also obtained a similar result in TECPR1-depleted HeLa cells ( Figures S5B and S5C ). All these data indicate that autophagosome maturation is defective in the absence of TECPR1.
To consolidate the role of TECPR1 in autophagosome maturation, we looked for any defect in autophagic flux in both TECPR1 wild-type and RNAi-depleted cells. In wild-type U 2 OS cells, LC3-II is dramatically accumulated upon CQ and Bafilomycin A1 (BafA1) (V-ATPase inhibitor) treatments due to the blockage in autophagic flux. In TECPR1-depleted U 2 OS cells, LC3-II accumulation also occurs in unstressed cells, and the fold induction of LC3-II upon CQ and BafA1 treatments is dramatically reduced (Figure 6C ), indicating that autophagic flux is impaired in TECPR1-depleted cells.
Although TECPR1 exclusively localizes to autolysosomes in our study, it has been implicated that TECPR1 might also have a function in phagophore biogenesis and maturation (Ogawa et al., 2011) . To investigate a possible role for TECPR1 in phagophore biogenesis and maturation, we detected endogenous Atg16 in TECPR1-depleted cells. Compared to wild-type cells, Atg16 puncta form but fail to accumulate in TECPR1-depleted cells ( Figures S6A and S6B ), indicating that phagophore maturation is not affected when TECPR1 is depleted. Furthermore, the number of endogenous Atg16 puncta still increases upon rapamycin treatment in TECPR1-depleted cells, suggesting that stress-induced phagophore biogenesis is not defective in the absence of TECPR1. In addition, the levels of Atg12-Atg5 remain unchanged in the absence of TECPR1 ( Figure S6C ). Hence, phagophore biogenesis and maturation are not defective in the absence of TECPR1. To exclude another possibility that TECPR1 may be essential for the lysosomal activity and therefore affect autophagosome consumption indirectly, we examined the lysosomal activity in TECPR1-depleted cells using cathepsin L processing as readout. The processing of cathepsin L from the precursor form to its mature form is only mildly reduced in the TECPR1-depleted cells compared to that in wild-type cells (Figures S6D and S6E ). In contrast, as a positive control, cathepsin L processing is dramatically reduced in the CQ-treated cells (Figure S6F ). These data suggest that TECPR1 is not likely to be essential for the lysosomal activity.
TECPR1 Binds to PtdIns(3)P in an Atg12-Atg5-Dependent Manner TECPR1 possesses a PH domain, which is known to bind phosphoinositides. In autophagy, the class III phosphatidylinositol 3-kinase plays a central role in autophagosome biogenesis and maturation (Backer, 2008; Funderburk et al., 2010; Simonsen and Tooze, 2009 ). The production of PtdIns(3)P on the autophagosome membrane is critical for developing a platform to recruit protein(s) for autophagosome formation, yet very few proteins that are involved in autophagy are known to bind PtdIns(3)P.
To investigate the type of lipid(s) that the PH domain of TECPR1 might bind, we performed a protein-lipid overlay assay (PIP Strips) containing eight phosphoinositides and other biologically active lipids ( Figure 7A ). The recombinant PH domain of TECPR1 purified from HEK293T cells ( Figure 7B , lane 1) displays a strong and specific binding to PtdIns(3)P ( Figure 7C, panel I) . Unexpectedly, the full-length TECPR1 alone purified from HEK293T cells ( Figure 7B , lane 2) loses its affinity for PtdIns(3)P ( Figure 7C, panel II) . We reasoned that the association between PtdIns(3)P and TECPR1 might be regulated by Atg12-Atg5, given their physical interaction. To test this hypothesis, we coexpressed and purified the Atg12-Atg5-TECPR1 complex from HEK293T cells ( Figure 7B , lane 3) and tested its lipid binding activity. In the HEK293T overexpression system, only a portion of Atg5 is conjugated to Atg12 that could be readily detected by western blotting but barely detected by Coomassie blue staining ( Figure 7B, lanes 3 and 8) . Remarkably, this Atg12-Atg5-TECPR1 complex specifically binds PtdIns(3)P ( Figure 7C , panel III). As a control, the purified Atg12-Atg5-Atg16 complex ( Figure 7B , lane 4) has no detectable PtdIns(3)P binding activity ( Figure 7C, panel IV) . The PtdIns(3)P binding of the Atg12-Atg5-TECPR1 complex is dependent on the PH domain of TECPR1 as deletion of this domain ( Figure 7B , lane 5) abolishes PtdIns(3)P association ( Figure 7C, panel V) . A conjugation mutant form of Atg5 (Atg5 K130R) that lacks Atg12 conjugation ( Figure 7B , lanes 6 and 9), displays no detectable PtdIns(3)P binding activity (Figure 7C , panel VI), indicating that Atg12 conjugation is required for the PtdIns(3)P binding of Atg5-TECPR1.
Since the Atg12-Atg5 associated TECPR1, but not TECPR1 alone, is able to bind PtdIns(3)P, it is likely that the PH domain of TECPR1 is normally embedded, and the binding of the Atg12-Atg5 conjugate to the AIR region of TECPR1 may cause a conformational change to expose the PH domain for PtdIns(3)P binding. To test this possibility, we purified the AIR-deleted (DAIR) TECPR1 from the HEK293T cells ( Figure 7B, lane 7) . As expected, the purified AIR-deleted (DAIR) TECPR1 exhibits strong PtdIns(3)P binding activity ( Figure 7C , panel VII) that is comparable to the Atg12-Atg5-associated TECPR1. These data suggest that the AIR domain of TECPR1 indeed blocks the access of the PH domain to PtdIns(3)P in vitro.
To evaluate the contribution of PtdIns(3)P binding to the function of TECPR1 in autophagy, we tested the requirement of different domains of TECPR1 in the complementation assay (Figure 7D) . The autophagosome maturation defects (shown as the accumulation of LC3-II and p62) in TECPR1-depleted cells could be fully rescued by the expression of wild-type TECPR1 but not the vector alone. The PH-deleted TECPR1 also failed to complement, suggesting that the PtdIns(3)P binding is required for the autophagic function of TECPR1. Interestingly, the AIR-deleted TECPR1 could fully complement the autophagic defects in TECPR1-depleted cells, which is consistent with its robust PtdIns(3)P binding activity. We further investigated if the subcellular localization of TECPR1 in unstressed or challenged cells is affected by PtdIns(3)P production. The lysosomal distribution of TECPR1 in the unstressed cells was not significantly affected by the treatment of a class III phosphatidylinositol 3-kinase (PI3K) inhibitor 3-methyladenine (3-MA) ( Figure S7 ). Upon rapamycin or CQ treatment, the autolysosomal localization of TECPR1 was dramatically increased. Remarkably, autolysosomal localization of TECPR1 was severely impaired by 3-MA treatment, suggesting a requirement for the PI3K activity in TECPR1 localization ( Figure S7 ). As a positive control, stress-induced LC3 puncta were diminished in the 3-MA-treated cells (data not shown). All these data support an essential role of PtdIns(3)P binding in the autophagic function of TECPR1.
DISCUSSION
In this study, we demonstrate that TECPR1 controls autophagosome maturation by interacting with both Atg12-Atg5 and PtdIns(3)P. TECPR1 interacts with Atg12-Atg5 in a subcomplex that is mutually exclusive from the Atg12-Atg5-Atg16 complex. Additionally, TECPR1 specifically localizes to and recruits the Atg12-Atg5 conjugate to the autolysosome. TECPR1 depletion leads to accumulation of autophagic substrates including p62 and lipidated LC3 (LC3-II). TECPR1-deficient cells accumulate autophagic vacuoles. Moreover, autophagosome maturation and autophagic flux are blocked in TECPR1-depleted cells. Importantly, PtdIns(3)P binding of TECPR1 through the PH domain, which might be regulated by the Atg12-Atg5 conjugate in an autoinhibitory manner ( Figure 7E ), is essential for the autophagic function of TECPR1. Taken together, these data demonstrate that TECPR1 plays a critical role in autophagosome maturation. We anticipate that TECPR1 might function as a tethering factor to join autophagosomes with lysosomes through its association of Atg12-Atg5 and PtdIns(3)P; such action might initiate autophagosome-lysosome fusion. TECPR1 was recently identified as a component of the autophagy interaction network which consists of hundreds of proteins interacting with the core autophagy machinery (Behrends et al., 2010) . In this network, it was found that TECPR1 interacts with Atg5; this interaction was also reported in another study by Ogawa et al. (Ogawa et al., 2011) . Interestingly, in both studies, TECPR1 has been reported to interact with proteins in addition to Atg5, including WIPI-2, Atg3, TTC15 (TPR coatomer ε), and the chaperonin complex. These proteins were not identified in our purified TECPR1 cellular complex, probably due to relatively weak interactions. Behrends et al. reported that deletion of TECPR1 leads to LC3-II accumulation (Behrends et al., 2010) . However, Ogawa et al. suggested that TECPR1 is more important in selective autophagy against pathogens than canonical autophagy, since LC3-II conjugation upon autophagic stresses remains efficient in TECPR1 knockout cells (Ogawa et al., 2011) .
In contrast, through a comprehensive approach, we have established a rather surprising role for TECPR1 in autophagosome maturation. We observed that phagophore and autophagosome formation are not defective upon TECPR1 depletion, suggesting that TECPR1 does not play a critical role in autophagosome biogenesis. Strikingly, autophagosomes indicated by LC3-II and p62 staining are significantly accumulated in TECPR1-deficient cells, indicating a blockage in autophagosome maturation instead. It is currently unclear what causes these discrepancies; autophagosome maturation defects might be overlooked by the other groups.
Phosphoinositides are critical for signal transduction of membrane trafficking. PtdIns(3)P production is essential for autophagosome biogenesis (Backer, 2008; Funderburk et al., 2010) . Several pieces of evidence have also suggested a role for PtdIns(3)P in autophagosome maturation. PtdIns(3)P is important for membrane curvature sensing and maintenance by the PI3KC3 Sun et al., 2008) . Additionally, depletion of PtdIns(3)P decreases membrane curvature and impedes membrane expansion (Hubner et al., 1998; Kovacs et al., 2000) . Conversely, accumulation of PtdIns(3)P either by mutation of phosphatases (Taguchi-Atarashi et al., 2010) or blockage of vacuolar degradation (Wurmser and Emr, 1998) affects autophagosome maturation. It has been reported that phagophore localization of the Atg12-Atg5-Atg16 complex is dependent on the presence of PtdIns(3)P (Fujita et al., 2008 ). Here we show that PtdIns(3)P contributes to autophagosome maturation through the Atg12-Atg5-TECPR1 complex and is critical for the autolysosome localization of TECPR1. TECPR1 contains a PH domain that specifically interacts with PtdIns(3)P in vitro. Although most characterized PH domains bind PtdIns(3,4,5)P3, PtdIns(4,5)P2, and PtdIns(3,4)P2 with high affinity, some PH domains indeed display PtdIns(3)P binding specificity (Dowler et al., 2000) . Interestingly, the TECPR1 PtdIns(3)P binding requires not only its PH domain but also its interaction with the conjugated Atg12-Atg5 (Figure 7 ). Both Ogawa et al. and our group showed that full-length TECPR1 fails to interact with PtdIns(3)P by itself. Ogawa et al. implied that TECPR1 might bind PtdIns(3)P indirectly by interacting with WIPI2, a PtdIns(3)P binding protein (Ogawa et al., 2011) . However, using purified recombinant proteins, we showed that the PH domain alone, Atg12-Atg5-associated TECPR1, and AIRdeleted TECPR1 are capable of binding PtdIns(3)P, suggesting that the interaction of Atg12-Atg5 might expose the PH domain of TECPR1 and allow TECPR1 to bind PtdIns(3)P directly ( Figure 7E ).
The AIR domain of TECPR1 mediates the interaction with the Atg12-Atg5 conjugate, but this domain might also serve as an autoinhibitory domain to block the PH domain from PtdIns(3)P binding. The pleiotropic functions of the AIR domain make it difficult to further dissect the requirement of the Atg12-Atg5-TECPR1 complex in autophagy. It is crucial in future studies to identify a mutation of TECPR1 in the AIR domain that only disrupts the Atg12-Atg5 interaction without affecting the protein conformation, which probably requires more detailed information about the binding surface through crystallographic analysis.
Autophagic vacuole maturation is defective in certain human diseases including lysosomal storage disease (Cao et al., 2006; Chevrier et al., 2010; Raben et al., 2008) and Danon disease (Nishino et al., 2000) . Autophagosome maturation appears not to be essential for animal development, which is best illustrated in LAMP-2 knockout mice. In these cells, there is an extensive accumulation of autophagic vacuoles, yet LAMP-2 knockout mice could have an almost normal life span (Tanaka et al., 2000) . However, autophagic vacuole accumulation is still problematic, as the deficiency of LAMP-2 leads to multiple human diseases including cardiomyopathy and Danon disease (Nishino et al., 2000; Tanaka et al., 2000) . Also, LAMP-2-deficient cells showed a reduced bacterial killing capacity caused by an impaired fusion of endo-lysosome with phagosomes (Beertsen et al., 2008; Binker et al., 2007) . It is possible that TECPR1 and LAMP-2 share common mechanisms in autophagosome maturation. Understanding the molecular mechanism of this process should provide insights into the pathogenesis of these diseases, and pave the way for therapeutic drug design.
EXPERIMENTAL PROCEDURES Reagents
The anti-TECPR1 antibody was generated by Cell Signaling Technology. Other antibodies used in this study include anti-FLAG (Sigma), anti-HA (Roche), anti-Myc (Santa Cruz), anti-EEA1 (Abcam), anti-LAMP-1 (Abcam), anti-LAMP-2 (Santa Cruz), anti-LC3 (Sigma), anti-Atg5 (MBL International), anti-Atg16 (MBL International), and anti-p62 (MBL International).
Tandem Affinity Purification
The Atg5 coding sequence was inserted between BamHI and NotI cleavage sites to generate the reading frame of ZZ-Atg5-FLAG. The tandem affinity purification was performed as described before (Sun et al., 2008) .
Immunofluorescence Staining
Cells seeded into 6-well plates with coverslips were fixed with cold methanol (À20 C) and blocked with blocking buffer (2.5% BSA + 0.1% Triton X-100 in PBS). After incubation with primary and secondary antibodies, samples were examined under a laser scanning confocal microscope (Zeiss LSM 510 META UV/Vis).
Electron Microscope Analysis
For transmission electron microscopy, cells were fixed in 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium cacodylate buffer (pH 7.4). For immunoelectron microscopy (Tokuyasu method), cells were fixed in freshly made 2% paraformaldehyde in 0.1 M PBS containing 0.2% glutaraldehyde, pH 7.2-7.4.
Protein-Lipid Overlay Assay
The FLAG-tagged recombinant proteins were purified from mammalian cells as described (Sun et al., 2010 (Sun et al., , 2011 . PIP Strips (Echelon Biosciences Inc.) were blocked in blocking buffer (PBS with 1% nonfat dry milk) for 1 hr at room temperature and then incubated with 1.0 mg/ml indicated FLAG-tagged protein in blocking buffer at 4 C overnight. After three washes with PBS-T, strips were immunoblotted with anti-FLAG antibody. Please see the Supplemental Information for more experimental details.
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